Terminalia mantaly H. Perrier is a plant used in traditional medicine for the treatment of various pathologies. However, Terminalia mantaly H. Perrier could present potential health effects on patients. In order to de...Terminalia mantaly H. Perrier is a plant used in traditional medicine for the treatment of various pathologies. However, Terminalia mantaly H. Perrier could present potential health effects on patients. In order to determine the possible cardiotoxic effects of the hydro-alcoholic extract of the bark of Terminalia mantaly H. Perrier, (HAEBTM) forty (40) rats distributed randomly into 4 groups, including 10 animals per group (5 males and 5 females) were used. Animals in group 1 received distilled water and were used as a control group. On the other hand, groups 2, 3, 4 received oral administration a volume of the hydroalcoholic extract of Terminalia mantaly H. Perrier corresponding to 1 mL/100g of body weight at 150 mg/kg, 300 mg/kg, 600 mg/kg, respectively. The extract was administered daily at the same time for 28 days and serum was collected once a week to evaluate cardiac biochemical markers using spectrophotometric methods using a Cobas C311 HITACHI biochemistry system. After one month of study, all rats were euthanized by overdose of ether, and the hearts of the rats were removed for gross morphological and histopathological analysis. Results were analysed using variance analysis (ANOVA) to compare outcomes as a function of doses administered and treatment times. The biochemical parameters ALT, LDH, CPK, CPKMB showed no significant change (p Terminalia mantaly showed no lesions, edema and necrosis. These results suggest that the hydroalcoholic extract of Terminalia mantaly did not interfere with the functioning or alter the integrity of the heart.展开更多
Distinguishing between nonalcoholic steatohepatitis(NASH) and advanced liver fibrosis is the key for clinical diagnosis of non-alcoholic fatty liver disease(NAFLD). Liver biopsy, which is widely used for diagnosis of ...Distinguishing between nonalcoholic steatohepatitis(NASH) and advanced liver fibrosis is the key for clinical diagnosis of non-alcoholic fatty liver disease(NAFLD). Liver biopsy, which is widely used for diagnosis of liver diseases at present, has many drawbacks, such as being invasive, expensive and unstable. This article compares and summarizes the commonly used non-invasive diagnostic methods, including their diagnostic parameters, advantages and disadvantages, in order to provide a useful reference for the diagnosis of NASH.展开更多
This paper introduced a GC-MS/MS analysis method and its application in bio-marker.By contrast,this method is specially good in inspecting a trace bio-marker determining the nature and fixing quantify.GC-MS/MS can ins...This paper introduced a GC-MS/MS analysis method and its application in bio-marker.By contrast,this method is specially good in inspecting a trace bio-marker determining the nature and fixing quantify.GC-MS/MS can inspect nor_cholestane(C27,24,21) which GC-MS can’t do.Very importantly,this new method provided new bio-marker parameter for an organic geochemistry study.展开更多
通过白令海北部陆坡区B2-9站位沉积物柱样高分辨率的生物标志物(菜子甾醇、甲藻甾醇、长链烯酮、n-C30-diol)提取和分析,获得了近1万年来浮游植物群落和初级生产力、高碳烷烃输入与陆源植被变化等相关记录,研究结果显示,全新世以来表层...通过白令海北部陆坡区B2-9站位沉积物柱样高分辨率的生物标志物(菜子甾醇、甲藻甾醇、长链烯酮、n-C30-diol)提取和分析,获得了近1万年来浮游植物群落和初级生产力、高碳烷烃输入与陆源植被变化等相关记录,研究结果显示,全新世以来表层浮游植物和初级生产力都经历了"高-低-高"的变化过程,并具有明显的阶段性,可能受控于陆架坡折处海冰的分布、上层海洋营养盐供应和全新世气候与环境的变迁;浮游植物群落结构较为稳定,硅藻是初级生产力的主要贡献者,甲藻次之,颗石藻和黄绿藻比前两者低了1个数量级,硅藻与甲藻之间具有明显的竞争关系,前者明显占据优势,是白令海有机碳汇的主要贡献者;正构烷烃总量分别在7.8 ka BP,6.7 ka BP和5.4 ka BP,经历了3次阶梯状的下降过程,并呈现出4个相对稳定的阶段,其主要受控于早全新世海平面上升以及周边陆地植被源区的气候与环境变化;正构烷烃分子组合特征显示其来自陆地高等植物、且陆源植被结构较为稳定,木本植物占据优势;单体碳同位素研究表明正构烷烃的主碳峰为n-C27,对烷烃总量的贡献最大,可能与当时陆源繁盛的木本植物及输入有关,含量较高的n-C23则可能主要来源于北半球沿海广泛分布的一类沉水植物。展开更多
Colorectal cancer （CRC）, the third most commonly di- agnosed type of cancer in men and women worldwide is recognized as a complex multi-pathway disease, an observation sustained by the fact that histologically ident...Colorectal cancer （CRC）, the third most commonly di- agnosed type of cancer in men and women worldwide is recognized as a complex multi-pathway disease, an observation sustained by the fact that histologically identical tumors may have different outcome, including various response to therapy. Therefore, particularly in early and intermediate stage （stages Ⅱ and Ⅲ, respec- tively） CRC, there is a compelling need for biomarkers helpful of selecting patients with aggressive disease that might benefit from adjuvant and targeted therapy. Histopathological examination shows that likely other solid tumors the development and progression of hu- man CRC is not only determined by genetically abnor- mal cells, but also by intricate interactions between malignant cells and the surrounding microenvironment. This has led to reconsider the features of tumor mi- croenvironment as potential predictive and prognostic biomarkers. Among the histopathological biomarkers, tumor budding （i.e., the presence of individual cells and small clusters of tumor cells at the tumor invasive front）has received much recent attention, particularly in the setting of CRC. Although its acceptance as a reportable factor has been held back by a lack of uniformity with respect to qualitative and quantitative aspects, tumor budding is now considered as an independent adverse prognostic factor in CRC that may allow for stratifica- tion of patients into risk categories more meaningful than those defined by tumor-node-metastasis staging alone, and also potentially guide treatment decisions, especially in T2-T3 NO （stage Ⅱ） CRCs.展开更多
文摘Terminalia mantaly H. Perrier is a plant used in traditional medicine for the treatment of various pathologies. However, Terminalia mantaly H. Perrier could present potential health effects on patients. In order to determine the possible cardiotoxic effects of the hydro-alcoholic extract of the bark of Terminalia mantaly H. Perrier, (HAEBTM) forty (40) rats distributed randomly into 4 groups, including 10 animals per group (5 males and 5 females) were used. Animals in group 1 received distilled water and were used as a control group. On the other hand, groups 2, 3, 4 received oral administration a volume of the hydroalcoholic extract of Terminalia mantaly H. Perrier corresponding to 1 mL/100g of body weight at 150 mg/kg, 300 mg/kg, 600 mg/kg, respectively. The extract was administered daily at the same time for 28 days and serum was collected once a week to evaluate cardiac biochemical markers using spectrophotometric methods using a Cobas C311 HITACHI biochemistry system. After one month of study, all rats were euthanized by overdose of ether, and the hearts of the rats were removed for gross morphological and histopathological analysis. Results were analysed using variance analysis (ANOVA) to compare outcomes as a function of doses administered and treatment times. The biochemical parameters ALT, LDH, CPK, CPKMB showed no significant change (p Terminalia mantaly showed no lesions, edema and necrosis. These results suggest that the hydroalcoholic extract of Terminalia mantaly did not interfere with the functioning or alter the integrity of the heart.
基金Supported by Traditional Chinese Medicine Development Program of Shandong Province (2021Q097)。
文摘Distinguishing between nonalcoholic steatohepatitis(NASH) and advanced liver fibrosis is the key for clinical diagnosis of non-alcoholic fatty liver disease(NAFLD). Liver biopsy, which is widely used for diagnosis of liver diseases at present, has many drawbacks, such as being invasive, expensive and unstable. This article compares and summarizes the commonly used non-invasive diagnostic methods, including their diagnostic parameters, advantages and disadvantages, in order to provide a useful reference for the diagnosis of NASH.
文摘This paper introduced a GC-MS/MS analysis method and its application in bio-marker.By contrast,this method is specially good in inspecting a trace bio-marker determining the nature and fixing quantify.GC-MS/MS can inspect nor_cholestane(C27,24,21) which GC-MS can’t do.Very importantly,this new method provided new bio-marker parameter for an organic geochemistry study.
文摘通过白令海北部陆坡区B2-9站位沉积物柱样高分辨率的生物标志物(菜子甾醇、甲藻甾醇、长链烯酮、n-C30-diol)提取和分析,获得了近1万年来浮游植物群落和初级生产力、高碳烷烃输入与陆源植被变化等相关记录,研究结果显示,全新世以来表层浮游植物和初级生产力都经历了"高-低-高"的变化过程,并具有明显的阶段性,可能受控于陆架坡折处海冰的分布、上层海洋营养盐供应和全新世气候与环境的变迁;浮游植物群落结构较为稳定,硅藻是初级生产力的主要贡献者,甲藻次之,颗石藻和黄绿藻比前两者低了1个数量级,硅藻与甲藻之间具有明显的竞争关系,前者明显占据优势,是白令海有机碳汇的主要贡献者;正构烷烃总量分别在7.8 ka BP,6.7 ka BP和5.4 ka BP,经历了3次阶梯状的下降过程,并呈现出4个相对稳定的阶段,其主要受控于早全新世海平面上升以及周边陆地植被源区的气候与环境变化;正构烷烃分子组合特征显示其来自陆地高等植物、且陆源植被结构较为稳定,木本植物占据优势;单体碳同位素研究表明正构烷烃的主碳峰为n-C27,对烷烃总量的贡献最大,可能与当时陆源繁盛的木本植物及输入有关,含量较高的n-C23则可能主要来源于北半球沿海广泛分布的一类沉水植物。
基金Supported by Ministero dell'Istruzione,dell'Università e della Ricerca,Target Project Oncologia 2006Alleanza Contro il Cancrothe Italian Association for Cancer Research,grant project No.IG5256
文摘Colorectal cancer （CRC）, the third most commonly di- agnosed type of cancer in men and women worldwide is recognized as a complex multi-pathway disease, an observation sustained by the fact that histologically identical tumors may have different outcome, including various response to therapy. Therefore, particularly in early and intermediate stage （stages Ⅱ and Ⅲ, respec- tively） CRC, there is a compelling need for biomarkers helpful of selecting patients with aggressive disease that might benefit from adjuvant and targeted therapy. Histopathological examination shows that likely other solid tumors the development and progression of hu- man CRC is not only determined by genetically abnor- mal cells, but also by intricate interactions between malignant cells and the surrounding microenvironment. This has led to reconsider the features of tumor mi- croenvironment as potential predictive and prognostic biomarkers. Among the histopathological biomarkers, tumor budding （i.e., the presence of individual cells and small clusters of tumor cells at the tumor invasive front）has received much recent attention, particularly in the setting of CRC. Although its acceptance as a reportable factor has been held back by a lack of uniformity with respect to qualitative and quantitative aspects, tumor budding is now considered as an independent adverse prognostic factor in CRC that may allow for stratifica- tion of patients into risk categories more meaningful than those defined by tumor-node-metastasis staging alone, and also potentially guide treatment decisions, especially in T2-T3 NO （stage Ⅱ） CRCs.
